Reactive stroma in human prostate cancer: induction of myofibroblast phenotype and extracellular matrix remodeling.
- Journal
- PubMed
In The Last Decade
doi.org/w83848073 →Countries where authors are citing Reactive stroma in human prostate cancer: induction of myofibroblast phenotype and extracellular matrix remodeling.
This map shows the geographic impact of Reactive stroma in human prostate cancer: induction of myofibroblast phenotype and extracellular matrix remodeling.. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Reactive stroma in human prostate cancer: induction of myofibroblast phenotype and extracellular matrix remodeling. with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Reactive stroma in human prostate cancer: induction of myofibroblast phenotype and extracellular matrix remodeling. more than expected).
Fields of papers citing Reactive stroma in human prostate cancer: induction of myofibroblast phenotype and extracellular matrix remodeling.
This network shows the impact of Reactive stroma in human prostate cancer: induction of myofibroblast phenotype and extracellular matrix remodeling.. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the Reactive stroma in human prostate cancer: induction of myofibroblast phenotype and extracellular matrix remodeling..
About Reactive stroma in human prostate cancer: induction of myofibroblast phenotype and extracellular matrix remodeling.
This paper, published in 2002, received 634 indexed citations . Written by Jennifer A. Tuxhorn, Gustavo E. Ayala, Vincent C. Smith, Truong D. Dang and David R. Rowley covering the research area of Oncology, Cancer Research and Pulmonary and Respiratory Medicine. It is primarily cited by scholars working on Pulmonary and Respiratory Medicine (286 citations), Molecular Biology (239 citations) and Oncology (190 citations). Published in PubMed.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.
This paper is also available at doi.org/w83848073.